Net profit of Zydus Lifesciences rose 13.80% to Rs 911.20 crore in the quarter ended September 2024 as against Rs 800.70 crore during the previous quarter ended September 2023. Sales rose 20.08% to Rs 5113.60 crore in the quarter ended September 2024 as against Rs 4258.60 crore during the previous quarter ended September 2023.
| Particulars | Quarter Ended |
| Sep. 2024 | Sep. 2023 | % Var. |
| Sales | 5113.60 | 4258.60 | 20 |
| OPM % | 28.58 | 26.91 | - |
| PBDT | 1504.50 | 1191.40 | 26 |
| PBT | 1270.90 | 1007.20 | 26 |
| NP | 911.20 | 800.70 | 14 |